The DOI matches its Crossref record.
Activation of telomerase in human lymphocytes and hematopoietic progenitor cells
Abstract
This is the first report describing up-regulation of telomerase activity in human normal cells. Telomerase, a ribonucleoprotein enzyme, has been thought to be involved in maintaining telomere length stability in germline and most cancer cells, but not in normal cells. However, in the present study, we demonstrate that telomerase activity is detectable at low levels in normal human T and B cells, increases by in vitro mitogenic stimulation, increases in hematopoietic progenitor cells upon their proliferation and differentiation, and decreases with aging. Understanding the regulation of telomerase activity in normal cells may provide important insights not only into the mechanisms of normal cellular senescence but also into the mechanisms of telomerase activity deregulation as part of cancer development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although we have to wait for the final report of the clinical trial, no significant adverse effects on normal tissues have been reported so far, even in hematopoietic cells, which may be highly susceptible to Telomelysin due to the presence of telomerase-positive stem cells. (35)”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [35]
In the citing paper
“We should consider the fact that some normal cells, including some tissue stem cells, express relatively high levels of telomerase, (35,36,117) raising questions regarding the safety of Telomelysin.”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [35]
Citations
Cited by
Sorted by citations
Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
“Expression of the telomerase-asso-Broccoli et al., 1995; Counter et al., 1995; Hiyama et al., 1995).”
Telomeres and telomerase: three decades of progress
Shay, J. W., & Wright, W. E. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0099-1 · Cited by 924
Self-citationHuman Telomerase and Its Regulation
Cong, Y.-S., Wright, W. E., & Shay, J. W. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.3.407-425.2002 · Cited by 898
“A number of studies have indicated that telomerase activity is modulated under particular physiological conditions during tissue development and homeostasis (105, 134, 249).”
BackgroundSelf-citationHeterogeneity in telomere length of human chromosomes
Lansdorp, P. M. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.5.685 · Cited by 886
Telomerase maintains telomere structure in normal human cells
Kenichi, M., Yu, E. Y., Shilagardi, K., Ben‐Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Seishi, M., DeCaprio, J. A., et al. (2006) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 738
Telomerase in the human organism
Collins, K., & Mitchell, J. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205083 · Cited by 616
Cdc13p: A Single-Strand Telomeric DNA-Binding Protein with a Dual Role in Yeast Telomere Maintenance
Nugent, C. I., Hughes, T., Lue, N. F., & Lundblad, V. (1996) · Science · doi:10.1126/science.274.5285.249 · Cited by 606
Kilian, A., Bowtell, D. D. L., Abud, H. E., Hime, G. R., Venter, D. J., Keese, P., Duncan, E. L., Reddel, R. R., & Jefferson, R. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2011 · Cited by 592
Telomere and telomerase in stem cells
Hiyama, E., & Hiyama, K. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603671 · Cited by 573
“TELOMERES AND TELOMERASE IN HEMATOPOIETIC STEM CELLS In the hematopoietic system, telomerase-expressing cells are stem cells with self-renewal potential and their early descendants (Hiyama et al., 1995; Morrison et al., 1996).”
BackgroundInfluentialSelf-citationThe biology of replicative senescence
Campisi, J. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00058-5 · Cited by 538
Härle-Bachor, C., & Boukamp, P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6476 · Cited by 492
Kyo, S. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.3.669 · Cited by 499
Disease states associated with telomerase deficiency appear earlier in mice with short telomeres
Herrera, E., Samper, E., Martín‐Caballero, J., Flores, J. M., Lee, H., & Blasco, M. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.2950 · Cited by 471
“…express telomerase, such as those of the hematopietic system, has been proposed to be due to down-regulation of telomerase activity with age (Hiyama et al., 1995) and/or to the possibility that the levels of telomerase activity present in those tissues are not sufficient to prevent telomere…”
BackgroundBeerman, I., Seita, J., Inlay, M. A., Weissman, I. L., & Rossi, D. J. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.04.016 · Cited by 445
“…of HSCs (Cheshier et al., 1999; Foudi et al., 2009; Wilson et al., 2008), combined with the expression of telomerase in HSCs (Broccoli et al., 1995; Hiyama et al., 1995; Morrison et al., 1996), minimizes the introduction of replicationbased errors and uncapping of telomeres during replication…”
BackgroundLin, J., Epel, E., Cheon, J., Kroenke, C., Sinclair, E., Bigos, M., Wolkowitz, O., Mellon, S., & Blackburn, E. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.09.012 · Cited by 426
“Hiyama et al. (1995) further examined telomerase activity in restingPBMCs from124 Japanese individuals ranging from 0 to 86 years.”
BackgroundRegulated expression of telomerase activity in human T lymphocyte development and activation.
Weng, N., Levine, B. L., June, C. H., & Hodes, R. J. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2471 · Cited by 401
“These results are consistent with two recent reports of telomerase expression in human peripheral blood T lymphocytes (22, 23 ), and with the demonstration that telomerase activity is inducible in unfractionated PBMC with mitogen stimulation (23).'Telomerase may thus have a broad role in the process of lymphocyte deve…”
BackgroundResultInfluentialTelomerase activity, cell proliferation, and cancer
Greider, C. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.90 · Cited by 408
Chiu, C., Dragowska, W., Kim, N. W., Vaziri, H., Yui, J., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1996) · STEM CELLS · doi:10.1002/stem.140239 · Cited by 388
Telomerase Activity in Hematopoietic Cells Is Associated with Self-Renewal Potential
Morrison, S. J., Prowse, K. R., Ho, P., & Weissman, I. L. (1996) · Immunity · doi:10.1016/s1074-7613(00)80316-7 · Cited by 394
Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2
Bianchi, G., Banfi, A., Mastrogiacomo, M., Notaro, R., Luzzatto, L., Cancedda, R., & Quarto, R. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00138-1 · Cited by 374
T cells and aging january 2002 update
Pawelec, G. (2002) · Frontiers in bioscience · doi:10.2741/a831 · Cited by 372
Regulation of Telomerase Activity in Immortal Cell Lines
Holt, S. E., Wright, W. E., & Shay, J. W. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.2932 · Cited by 361
“CD34(1) CD38 hematopoietic stem cells have very low levels of telomerase activity, while their dividing CD34(1) CD38(1) progeny have increased levels of telomerase activity (5, 14).”
Self-citationPawelec, G. (1998) · Frontiers in bioscience · doi:10.2741/a266 · Cited by 357
“(188) have shown that telomerase activity is detectable at very low levels in normal human T and B cells and that it increases greatly after mitogenic stimulation.”
Nair, S. K., Heiser, A., Boczkowski, D., Majumdar, A. S., Naoe, M., LEBKOWSKI, J. S., Vieweg, J., & Gilboa, E. (2000) · Nature Medicine · doi:10.1038/79519 · Cited by 348
“Telomerase activity is, however, present in proliferating tissues such as activated T and B cells, hematopoietic progenitors, germ cells and cells within intestinal and liver tissu”
BackgroundUnderstanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers
Kyo, S., Takakura, M., Fujiwara, T., & Inoue, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00878.x · Cited by 347
Forsyth, N. R., Wright, W. E., & Shay, J. W. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.690412.x · Cited by 345
Self-citationStem cells and aging: expanding the possibilities
Rao, M. S. R. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00224-x · Cited by 349
“Studies have shown that levels of telomerase activity increase in hematopoietic progenitor cells upon their proliferation and differentiation, and decrease with aging (Hiyama et al., 1995).”
BackgroundTelomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients
Agarwal, S., Loh, Y., McLoughlin, E. M., Huang, J., Park, I., Miller, J. D., Huo, H., Okuka, M., dos Reis, R. M., Loewer, S., et al. (2010) · Nature · doi:10.1038/nature08792 · Cited by 334
Hodes, R. J., Hathcock, K. S., & Weng, N. (2002) · Nature reviews. Immunology · doi:10.1038/nri890 · Cited by 317
“This has been shown most extensively for lymphocyte”
BackgroundExpression of human telomerase subunits and correlation with telomerase activity in cervical cancer.
Takakura, M., Kyo, S., Kanaya, T., Tanaka, M., & Inoue, M. (1998) · PubMed · Cited by 294
Telomerase Regulation, Cell Cycle, and Telomere Stability in Primitive Hematopoietic Cells
Engelhardt, M. M., Kumar, R., Albanell, J., Pettengell, R., Han, W., & Moore, M. A. S. (1997) · Blood · doi:10.1182/blood.v90.1.182 · Cited by 296
Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis
Blasco, M. A., Rizen, M., Greider, C. W., & Hanahan, D. (1996) · Nature Genetics · doi:10.1038/ng0296-200 · Cited by 287
T Cell Telomere Length in HIV-1 Infection: No Evidence for Increased CD4 + T Cell Turnover
Wolthers, K. C., Bea, G., Wisman, A., Otto, S. A., de Roda Husman, A.-M., Schaft, N., de Wolf, F., Goudsmit, J., Coutinho, R. A., van der Zee, A. G. J., et al. (1996) · Science · doi:10.1126/science.274.5292.1543 · Cited by 286
Progressive Telomere Shortening in Aplastic Anemia
Ball, S. E., Gibson, F. M., Rizzo, S., Tooze, J. A., Marsh, J. C. W., & Gordon‐Smith, E. C. (1998) · Blood · doi:10.1182/blood.v91.10.3582 · Cited by 288
Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)
Poole, J. C., Andrews, L. G., & Tollefsbol, T. O. (2001) · Gene · doi:10.1016/s0378-1119(01)00440-1 · Cited by 280
Detection of Telomerase Activity in Malignant and Nonmalignant Skin Conditions
Taylor, R. S., Ramirez, R. D., Ogoshi, M., Chaffins, M. L., Piatyszek, M. A., & Shay, J. W. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12345811 · Cited by 265
Self-citationTelomere lengthening and telomerase activation during human B cell differentiation
Weng, N., Granger, L., & Hodes, R. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10827 · Cited by 272
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer
Leao, R. R. N., Apolónio, J. D., Lee, D., Figueiredo, A., Tabori, U. Y., & Castelo‐Branco, P. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0422-8 · Cited by 273
Iwama, H., Ohyashiki, K., Ohyashiki, J. H., Hayashi, S., Yahata, N., Ando, K., Toyama, K., Hoshika, A., Takasaki, M., Mori, M., et al. (1998) · Human Genetics · doi:10.1007/s004390050711 · Cited by 265
“Circulating T (Hiyama et al. 1995; Pan et al. 1997) and B lymphocytes (Broccoli et al.”
BackgroundInfluentialSelf-citationThe genetics and clinical manifestations of telomere biology disorders
Savage, S. A., & Bertuch, A. A. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181f415b5 · Cited by 265
Cytotoxic T cell immunity against telomerase reverse transcriptase in humans
Minev, B., Hipp, J., Firat, H., Schmidt, J. D., Langlade‐Demoyen, P., & Zanetti, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070560797 · Cited by 260
Valenzuela, H. (2002) · Clinical Immunology · doi:10.1006/clim.2002.5271 · Cited by 254
Telomere Biology and Cardiovascular Disease
Fuster, J. J., & Andrés, V. (2006) · Circulation Research · doi:10.1161/01.res.0000251281.00845.18 · Cited by 239
Telomerase activity: A biomarker of cell proliferation, not malignant transformation
Belair, C. D., Yeager, T. R., Lopez, P. M., & Reznikoff, C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13677 · Cited by 237
Liu, K., Schoonmaker, M. M., Levine, B. L., June, C. H., Hodes, R. J., & Weng, N.-P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5147 · Cited by 233
Liu, K., Hodes, R. J., & Weng, N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.4826 · Cited by 234
“Stimulation of peripheral blood T cells through the TCR/CD3 complex alone or in combination with costimulatory receptor results in induction of telomerase activity (7, 17, 18).”
BackgroundRelationship between Physical Activity Level, Telomere Length, and Telomerase Activity
Ludlow, A. T., Zimmerman, J. B., Witkowski, S., Hearn, J. W., Hatfield, B. D., & Roth, S. M. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31817c92aa · Cited by 233
Diet, nutrition and telomere length
Paul, L. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.12.001 · Cited by 227
“Telomerase activity is also present in activated T-lymphocytes [8,9], although this does not result in maintenance of telomere length in T-lymphocytes but may partially compensate for loss of telomere repeats during cell division [10].”
BackgroundReplicative Aging and Gene Expression in Long-Term Cultures of Human Bone Marrow Stromal Cells
Banfi, A., Bianchi, G., Notaro, R., Luzzatto, L., Cancedda, R., & Quarto, R. (2002) · Tissue Engineering · doi:10.1089/107632702320934001 · Cited by 229
“21,35,36 Telomerase activity has also been detected in human hematopoietic progenitors 37,38 and in other progenitor cells obtained from different tissues.”
Kanaya, T., Kyo, S., Hamada, K., Takakura, M., Kitagawa, Y., Harada, H., & Inoue, M. (2000) · PubMed · Cited by 222
IL-7-Dependent Extrathymic Expansion of CD45RA+ T Cells Enables Preservation of a Naive Repertoire
Soares, M. V. D., Soares, D., Borthwick, N., Maini, M. K., Janossy, G., Salmon, M., & Akbar, A. N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.5909 · Cited by 216
Ballew, B. J., & Savage, S. A. (2013) · Expert Review of Hematology · doi:10.1586/ehm.13.23 · Cited by 214
Selection and Extended Growth of Murine Epidermal Stem Cells in Culture
Bickenbach, J. R., & Chism, E. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4163 · Cited by 208
Telomerase Activity in Candidate Stem Cells From Fetal Liver and Adult Bone Marrow
Yui, J., Chiu, C.-P., & Lansdorp, P. M. (1998) · Blood · doi:10.1182/blood.v91.9.3255 · Cited by 216
Reassessing target antigens for adoptive T-cell therapy
Hinrichs, C. S., & Restifo, N. P. (2013) · Nature Biotechnology · doi:10.1038/nbt.2725 · Cited by 216
Role of Telomerase in Normal and Cancer Cells
Meyerson, M. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2626 · Cited by 205
Telomerase activity is detected in pancreatic cancer but not in benign tumors.
Hiyama, E., Kodama, T. S., Shinbara, K., Iwao, T., Itoh, M., Hiyama, K., Shay, J. W., Matsuura, Y., & Yokoyama, T. (1997) · PubMed · Cited by 208
Self-citationWeng, N., Palmer, L. D., Levine, B. L., Lane, H. C., June, C. H., & Hodes, R. J. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb01026.x · Cited by 201
Clinical utility of telomerase in cancer
Hiyama, E., & Hiyama, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205070 · Cited by 203
Self-citationSon, N. H., Murray, S., Yanovski, J., Hodes, R. J., & Weng, N.-P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1191 · Cited by 200
Telomerase regulation during entry into the cell cycle in normal human T cells.
Buchkovich, K. J., & Greider, C. W. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.9.1443 · Cited by 198
In vivo telomere dynamics of human hematopoietic stem cells
Notaro, R., Cimmino, A., Tabarini, D., Rotoli, B., & Luzzatto, L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13782 · Cited by 195
Albanell, J., Engelhardt, M., Han, W., Moore, M. A. S., Lonardo, F., Rusch, V., Langenfeld, J., Klimstra, D., Venkatraman, E., & Dmitrovsky, E. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.21.1609 · Cited by 193
Resistance of mature T cells to oncogene transformation.
Newrzela, S., Cornils, K., Li, Z.-X., Baum, C., Brugman, M., Hartmann, M., Meyer, J., Hartmann, S., Hansmann, M., Fehse, B., et al. (2008) · Blood · doi:10.1182/blood-2007-12-128751 · Cited by 196
Harley, C. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205076 · Cited by 194
The fetal programming of telomere biology hypothesis: an update
Entringer, S., de Punder, K., Buß, C., & Wadhwa, P. D. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0151 · Cited by 194
Immunosenescence: Role and measurement in influenza vaccine response among the elderly
Targonski, P. V., Jacobson, R. M., & Poland, G. A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.025 · Cited by 186
Wiseman, D. H. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.10.010 · Cited by 183
“Telomerase expression is variably high in cells endowed with self-renewal capacity, including HSCs [150], and correlates strongly with histologic evidence of malignant cells in many tissues [151].”
BackgroundAlternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas
Scheel, C., Schaefer, K., Jauch, A. S., Keller, M., Wai, D., Brinkschmidt, C., van Valen, F., Boecker, W., Dockhorn‐Dworniczak, B., & Poremba, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204493 · Cited by 181
Clinical implications of telomerase in cancer
Kim, N. W. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00057-9 · Cited by 179
Hou, M., Xu, D., Björkholm, M., & Gruber, A. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.519 · Cited by 175
Hiyama, E., & Hiyama, K. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00709-7 · Cited by 197
Self-citationIn vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus
Kishimoto, H., Kojima, T., Watanabe, Y., Kagawa, S., Fujiwara, T., Uno, F., Teraishi, F., Kyo, S., Mizuguchi, H., Hashimoto, Y., et al. (2006) · Nature Medicine · doi:10.1038/nm1404 · Cited by 179
“Other possible explanations of false-positive detection include either that GFP protein itself was produced in the primary tumor spread into regional lymph nodes or that high doses of OBP-401 entered nodes and incidentally replicated in normal lymphocytes in that they have low telomerase activit”
BackgroundHypoxia Extends the Life Span of Vascular Smooth Muscle Cells through Telomerase Activation
Minamino, T., Mitsialis, S. A., & Kourembanas, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3336-3342.2001 · Cited by 179
“Recent studies indicate that telomerase activity is also present in highly proliferative somatic cell types, such as activated lymphocytes (7).”
Telomere maintenance mechanisms and cellular immortalization
Colgin, L. M., & Reddel, R. R. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80014-8 · Cited by 177
Yashima, K., Litzky, L. A., Kaiser, L. R., Rogers, T. E., Lam, S. C., Wistuba, I. I., Milchgrub, S., Srivastava, S., Piatyszek, M. A., Shay, J. W., et al. (1997) · PubMed · Cited by 175
Self-citationTelomerase Activity Concentrates in the Mitotically Active Segments of Human Hair Follicles
Ramirez, R. D., Wright, W. E., Shay, J. W., & Taylor, R. S. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12285654 · Cited by 174
Self-citationNiewisch, M. R., & Savage, S. A. (2019) · Expert Review of Hematology · doi:10.1080/17474086.2019.1662720 · Cited by 189
Kyo, S., & Inoue, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205163 · Cited by 180
Hooijberg, E., Ruizendaal, J. J., Snijders, P. J. F., Taanman-Kueter, E. W., Walboomers, J. M. M., & Spits, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4239 · Cited by 168
Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes
Fauce, S. R., Jamieson, B. D., Chin, A. C., Mitsuyasu, R. T., Parish, S. T., Ng, H. L., Ramirez, C. M., Yang, O. O., Harley, C. B., & Effros, R. B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7400 · Cited by 171
Refining the telomere-telomerase hypothesis of aging and cancer
Holt, S. E., Shay, J. W., & Wright, W. E. (1996) · Nature Biotechnology · doi:10.1038/nbt0796-836 · Cited by 168
Self-citationLack of cell cycle regulation of telomerase activity in human cells
Holt, S. E., Aisner, D. L., Shay, J. W., & Wright, W. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10687 · Cited by 166
Self-citationThe disparity between human cell senescence in vitro and lifelong replication in vivo
Rubin, H. (2002) · Nature Biotechnology · doi:10.1038/nbt0702-675 · Cited by 171
“For example, variable activities of telomerase occur in normal bone marrow and peripheral blood leukocyte”
BackgroundTelomerase and cancer: revisiting the telomere hypothesis
Autexier, C., & Greider, C. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10042-6 · Cited by 178
Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease
Kojima, H., Yokosuka, O., Imazeki, F., Saisho, H., & Omata, M. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024303 · Cited by 163
Telomerase in the early detection of cancer.
Shay, J. W., & Gazdar, A. F. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.2.106 · Cited by 162
Self-citationHiyama, E., Hiyama, K., Yokoyama, T., & Shay, J. W. (2001) · Neoplasia · doi:10.1038/sj.neo.7900134 · Cited by 165
Self-citationRegulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase
Kharbanda, S. M., Kumar, V., Dhar, S., Pandey, P., Chen, C., Majumder, P. K., Yuan, Z.-M., Whang, Y. E., Strauss, W. M., Pandita, T. K., et al. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00483-8 · Cited by 170
“Because telomerase activity is low in most somatic cells, telomeres shorten as cells progress through replicative cycles [9–13].”
Broccoli, D., Godley, L. A., Donehower, L. A., Varmus, H. E., & de Lange, T. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3765 · Cited by 156
“Telomerase activity is upregulated upon mitogenic stimulation of human peripheral blood lymphocytes (31), increased during in vitro culturing of primary mouse cells (12), and repressed during terminal differentiation of human and mouse cell lines (56).”
BackgroundHuman diseases of telomerase dysfunction: insights into tissue aging
Garcia, C. K., Wright, W. E., & Shay, J. W. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm644 · Cited by 161
Self-citationTelomere attrition as ageing biomarker.
Bekaert, S., Meyer, T. D., & Oostveldt, P. V. (2005) · PubMed · Cited by 158
Regulation of Telomere Length and Telomerase in T and B Cells
Weng, N., Hathcock, K. S., & Hodes, R. J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80597-x · Cited by 157
Molecular mechanisms of age-related hearing loss
Seidman, M. D., Ahmad, N., & Bai, U. (2002) · Ageing Research Reviews · doi:10.1016/s1568-1637(02)00004-1 · Cited by 154
Roles for c-Myc in Self-renewal of Hematopoietic Stem Cells
Satoh, Y., Matsumura, I., Tanaka, H., Ezoe, S., Sugahara, H., Mizuki, M., Shibayama, H., Ishiko, E., Ishiko, J., Nakajima, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400407200 · Cited by 154
Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas
Norrback, K.-F., Dahlenborg, K., Carlsson, R., & Roos, G. (1996) · Blood · doi:10.1182/blood.v88.1.222.222 · Cited by 156
Armstrong, L., Saretzki, G., Peters, H., Wappler, I., Evans, J., Hole, N., von Zglinicki, T., & Lako, M. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0269 · Cited by 153
Tahara, H., Yasui, W., Tahara, E., Fujimoto, J., Ito, K., Tamai, K., Nakayama, J., Ishikawa, F., Tahara, E., & Ide, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202458 · Cited by 151
Understanding immunosenescence and its impact on vaccination of older adults
Allen, J. C., Toapanta, F. R., Chen, W. H., & Tennant, S. M. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.11.002 · Cited by 161
“Since B and T cells undergo extensive clonal expansion throughout the duration of an immune response, several studies illustrate an ageassociated progressive shortening of telomeres that occurs as a consequence of activation and differentiation of lymphocytes [41, 42].”
BackgroundTelomerase regulation: not just flipping the switch
Aisner, D. L. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00268-4 · Cited by 153
Metadata
- Authors
- Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., & Yamakido, M.
- Affiliations
- Hiroshima University (JP)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-10
- Volume
- 155
- Issue
- 8
- Pages
- 3711-3715
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1516272650
- Cited by
- 853
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 10 · 2022: 6 · 2021: 11 · 2020: 9 · 2019: 13 · 2018: 11 · 2017: 8 · 2016: 13 · 2015: 15 · 2014: 17 · 2013: 20 · 2012: 17
- FWCI
- 38.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG07992, R01AG007992)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- telomerase, telomerase activity, lymphocytes, T cells, B cells, hematopoietic progenitor cells, mitogen stimulation, aging, cellular senescence, telomere length, carcinogenesis, normal cells
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aging, Base Sequence, Bone Marrow Cells, Cell Separation, Child, Child, Preschool, Enzyme Activation, Hematopoietic Stem Cells, Humans, Infant, Infant, Newborn, Leukocytes, Mononuclear, Lymphocyte Activation, Lymphocytes, Male, Middle Aged, Molecular Sequence Data, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
